Placebo-controlled, randomized trial of the addition of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide to titrated daily insulin glargine in patients with type 2 diabetes (AWARD-9).
| Image |  |
|---|---|
| Description | scientific article published on 14 March 2017 |
| Author/s |
author: Paolo Pozzilli Paul Norwood Zvonko Milicevic Melanie Davies |
| Publication date | March 14, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |